Ahead of the Bell: FDA rejects new label for Cephalon drug
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
 
 
Ahead of the Bell: FDA rejects new label for Cephalon drug
7 May 08, 11:17
A Food and Drug Administration panel voted against broadening the label for Cephalon Inc.'s pain drug Fentora, but analysts said Wednesday the drug may eventually be approved to treat non-cancer pain.
more

 

 
© 2007 nafdacnigeria.org